08.10.2015 • News

BP to Permanently Close Texas PX unit

BP has announced it will shutter its paraxylene (PX) plant at Texas City in the US with a capacity believed to exceed 1million t/y. The UK-based company cites market conditions as a reason for closing the plant.

BP will continue to operate its two other PX units in the US.

Without providing details the company said that following the closure of the PX facility it plans to reorganize its Texas City Chemicals plant to “better align and scale resources to meet our commitments and support our business goals, while maintaining safe, compliant and reliable operations.”

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.